“The relevance of Indonesia–Sinovac cooperation extends beyond pandemic mitigation, as it holds strong potential to advance sustainable vaccine research and innovation,” Irene said in a written statement received on Wednesday.
She delivered the invitation to Sinovac Chief Executive Yin Weidong during a Chinese New Year celebration hosted by the Beijing-based company on Feb. 6.
Since the onset of the COVID-19 pandemic, Sinovac has been a key partner in Indonesia’s public health response, helping expand vaccine access across the archipelago, Irene said.
The partnership, built on trust and shared responsibility, has supported Indonesia’s efforts to protect public health during the crisis, she added.
Irene said deeper cooperation with Sinovac would carry strategic value for Indonesia by strengthening its healthcare research ecosystem, including institutions and human resources in vaccine and biotechnology development.
Related news: Indonesia-Sinovac cooperation continues for mRNA vaccine development
She called for a focus on knowledge transfer and capacity building through joint research and innovation to ensure sustainable progress in the sector.
Such collaboration would also highlight the importance of collective preparedness in addressing future public health threats, she said.
“Investment in research, innovation and international collaboration is key to strengthening national and global healthcare systems,” Irene said.
Indonesia welcomes Sinovac’s long-term investment commitment, particularly in vaccine research and development, the healthcare industry ecosystem and workforce development, she added.
She expressed hope that expanded cooperation would deliver tangible benefits not only for Indonesia and China, but also for regional and global public health.
Sinovac, headquartered in Beijing, focuses on the research, development and production of vaccines and was among Indonesia’s main COVID-19 vaccine suppliers during the pandemic.
Related news: Health Ministry starts distributing Sinovac booster doses
Translator: Desca Lidya N, Nabil Ihsan
Editor: Rahmad Nasution
Copyright © ANTARA 2026
